Schedule 13D ownership disclosure
X4 PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98420X103
Event date: 2023-05-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-23-000346
- Form type
- SC 13D
- Filer
- Growth Equity Opportunities 18 VGE, LLC
- CIK
- CIK 1917895
- Filed
- May 26, 2023
- Reporting period
- May 18, 2023
- Description
- Schedule 13D beneficial ownership